Skip to main content
Signal8

Promino Nutritional Sciences Inc (MUSLF)

Promino Nutritional Sciences, Inc. engages in the production, distribution, and marketing of consumer-packaged nutritional products. It operates through the Canada and United States geographical segments. Its products include JAKTRX and Rejuvenate. The company was founded by Stuart Lowther on June 25, 2018 and is headquartered in Burlington, Canada.

Sector: Packaged Foods

Industry: Packaged Foods

Promino Nutritional Sciences Inc logo

Promino Nutritional Sciences Inc

OTC:MUSLFConsumer Defensive
-6.12%$0.0138
CLOSED
Mkt Cap$2.97M
EV$4.23M
Float213.15M
O/S215.18M
VOL5K sh
$ Vol$72
RVOL0.06×
Inst Own-
SI0.1%
Net Cash/Sh-$0.01
Dilution
Promino Nutritional Sciences Inc logoOTC:MUSLFClosed$0.0138-6.12%
Financials Summary
Revenue$1.51M
Net Income-$2.1M
Total Assets$141K
Free Cash Flow-$895K
Debt & Equity
Total Debt$1.28M
Total Equity-$5.54M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:3Reverse split
    Apr 1, 20243 shares → 1
Balance Sheet Details
Assets$141K
Liabilities$5.68M
Accounts Receivable$21K
Accounts Payable$4.24M
Inventory$83K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-31
Revenue$1.51M$2.8M$1.65M$686K
YoY Growth-46.2%69.8%140.6%-
Cost of Revenue$1.19M$3.56M$1.53M$572K
Gross Profit$314K-$758K$122K$114K
Gross Margin20.9%-27.1%7.4%16.6%
Research and Development$13K$13K$11K$30K
Selling, General, and Administrative$2.4M$6.47M$7.1M$2.6M
Other$0$24K$57K$105K
Total Operating Expenses$2.41M$6.51M$7.17M$2.74M
Operating Income (EBIT)-$2.1M-$7.27M-$7.05M-$4.15M
Operating Margin-139.3%-259.5%-427.1%-605.6%
Interest Expense$214K$94K$19K$21K
Interest Income$0$0$0$0
Other Income (Expense)$4K$25K$900K-$1.25M
Income Before Tax (EBT)-$2.1M-$7.24M-$6.15M-$5.4M
Income Tax Expense$0$0$0$0
Net Income-$2.1M-$7.24M-$6.15M-$5.4M
Net Income Margin-139.1%-258.6%-372.5%-787.9%
Supplementary Data
EPS-0.02-0.10-0.10-0.09
Diluted EPS-0.02-0.10-0.10-0.09
Weighted Average OS136.31M107.00M83.62M87.24M
EBITDA-$1.88M-$7.01M-$6.03M-$6.76M
EBITDA Margin-124.9%-250.3%-365.7%-986.3%
Balance Sheet
PeriodFY 2025FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-31
Assets
Current Assets
Cash and Cash Equivalents$17K$2K$345K$61K
Short-Term Investments$1K$0$0$0
Cash and Short-Term Investments$18K$2K$345K$61K
Accounts Receivable$21K$628K$299K$439K
Inventory$83K$1.01M$2.24M$239K
Other Current Assets$0$146K$565K$54K
Total Current Assets$141K$1.79M$3.44M$793K
Long-Term Assets
Property, Plant & Equipment Net$0$65K$54K$117K
Goodwill$0$0$0$0
Intangible Assets$0$0$0$0
Long-Term Investments$0$0$0$0
Deferred Tax Assets$0$0$0$0
Other Long-Term Assets$0$0$0$0
Total Long-Term Assets$0$65K$54K$117K
Other Assets$0$0$0$0
Total Assets$141K$1.86M$3.5M$910K
Liabilities
Current Liabilities
Accounts Payable$4.24M$4.1M$2.08M$1.7M
Short-Term Debt$1.28M$1.01M$485K$888K
Current Income Tax Payable$0$0$0$0
Current Unearned Revenue$0$0$0$0
Other Current Liabilities$161K$140K$0$0
Total Current Liabilities$5.68M$5.25M$2.56M$2.59M
Long-Term Liabilities
Long-Term Debt$0$18K$20K$73K
Long-Term Unearned Revenue$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0
Other Long-Term Liabilities$0$0$0$0
Total Long-Term Liabilities$0$18K$20K$73K
Other Liabilities$0$0$0$0
Total Liabilities$5.68M$5.26M$2.58M$2.66M
Stockholders' Equity
Preferred Stock$0$0$0$0
Common Stock$23.28M$16.78M$14.32M$7.65M
Retained Earnings-$34.44M-$23.17M-$15.93M-$9.78M
Comprehensive Income & Other-$367K-$269K-$45K$42K
Other Stockholders' Equity$5.62M$2.98M$2.53M$382K
Total Equity-$5.54M-$3.41M$913K-$1.75M
Minority Interest$0$0$0$0
Total Liabilities and Equity$141K$1.86M$3.5M$910K
Supplementary Data
Total Debt$1.28M$1.03M$505K$961K
Net Debt$1.26M$1.03M$161K$900K
Cash Flow Statement
PeriodFY 2025FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-31
Operating Activities
Net Income-$2.09M-$7.24M-$6.15M-$5.4M
Depreciation & Amortization$0$24K$57K$108K
Deferred Income Tax$0$428K-$1.1M$0
Stock-Based Compensation$0$693K$1.1M$0
Changes in Working Capital:
  Accounts Receivable$76K$0$0$0
  Inventory$403K$950K-$1.98M-$37K
  Accounts Payable$761K$0$0$0
  Other Working Capital-$3K$1.98M$6K$740K
Total Working Capital Change$1.24M$2.93M-$1.97M$703K
Other Non-Cash Items-$37K$19K$1.1M$3.08M
Net Cash from Operating-$895K-$3.15M-$6.96M-$1.51M
Investing Activities
Capital Expenditures$0-$16K-$26K-$7K
Acquisitions$0$0$0$0
Purchases of Investments-$27K$0$0$0
Sales of Investments$196K$0$0$0
Other Investing Activities$0$2K$0$1.3M
Net Cash from Investing$168K-$14K-$26K$1.29M
Financing Activities
Debt Repaid----
Common Stock Issuance$585K$2.45M$8.49M$0
Common Stock Repurchases$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing Activities$55K$3.01M$7.38M$155K
Net Cash from Financing$640K$3.01M$7.38M$155K
Forex Effect$6K-$184K-$115K$46K
Net Change in Cash-$81K-$342K$283K-$12K
Supplementary Data
Operating Cash Flow-$895K-$3.15M-$6.96M-$1.51M
Capital Expenditure$0-$16K-$26K-$7K
Free Cash Flow-$895K-$3.17M-$6.99M-$1.51M
Cash at Beginning$98K$345K$61K$73K
Cash at End$17K$2K$345K$61K